Global burden of pulmonary arterial hypertension in infants under 1 year, 1990–2023, and projections to 2040: a GBD 2023 analysis
Frontiers in Cardiovascular Medicine · 10.11.2026 · 13
DOI: 10.3389/fcvm.2026.1984074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 10.11.2026. Verfasst von Yanhua Wang und 12 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Using GBD 2023 data, we updated the global burden of infant PAH (1990–2023) and analyzed incidence, disability-adjusted life years (DALYs), and mortality by region, sex, age, and sociodemographic index (SDI). Trends were analyzed via joinpoint/log-linear regression, with ARIMA forecasting to 2040. The incidence remained stable (0.18 per 100,000, EAPC −0.04%), while DALYs and mortality declined (EAPCs −3.40%, −5.36%). Improvements were unequal: high-SDI regions fell most, and low-SDI regions experienced increasing cases and the slowest DALY reduction. India had the highest number of cases/deaths, and Afghanistan had the highest DALY rate. In half of the patients, mortality peaked at 6–11 months. The incidence of mortality was slightly greater for girls than for boys, and boys had greater DALYs/mortality. Projections to 2040 show persistent burden (DALYs 49.29, mortality 0.52 per 100,000) and unchanged sex disparities. Despite overall progress, socioeconomic inequalities remain. The stable incidence and increasing low-resource burden call for targeted, equitable interventions focusing on low-SDI countries, the perinatal period, and new-born males.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Wang, Y., Wang, D., Ding, Y., Han, X., Yan, L., Wang, Y., Lu, W., Xie, Y., Ma, N., Yang, Y., Guo, S., Li, J., & Hu, S. (2026). Global burden of pulmonary arterial hypertension in infants under 1 year, 1990–2023, and projections to 2040: a GBD 2023 analysis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1984074
Vancouver
Wang Y, Wang D, Ding Y, Han X, Yan L, Wang Y, et al. Global burden of pulmonary arterial hypertension in infants under 1 year, 1990–2023, and projections to 2040: a GBD 2023 analysis. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1984074
BibTeX
@article{Wang2026,
author = {Wang, Yanhua and Wang, Dan and Ding, Yiyi and Han, Xiuqi and Yan, Lei and Wang, Yi and Lu, Wei and Xie, Yuanyuan and Ma, Ning and Yang, Yan and Guo, Shuhao and Li, Jun and Hu, Siqi},
title = {Global burden of pulmonary arterial hypertension in infants under 1 year, 1990–2023, and projections to 2040: a GBD 2023 analysis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1984074}
}
EUVIMED